Thermo Fisher Scientific Inc. (TMO) is a Healthcare company in the Diagnostics & Research industry with a 72% Buy Score. Key strengths include Gross Margin (41.7%), Net Margin (15.0%), Return on Equity (13.0%). Our AI evaluates 8 fundamental categories including revenue growth, margin quality, balance sheet strength, cash flow generation, return on capital, and valuation metrics.
See how our AI analyzes TMO fundamentals to generate buy/sell signals and Strong Buy Scores.
Based on our AI-powered fundamental analysis, TMO has a Strong Buy Score of 72%, earning a "Buy" rating. This score synthesizes 8 key financial metrics to provide an objective investment signal.
Thermo Fisher Scientific Inc. demonstrates robust fundamentals across multiple categories. Key strengths include Gross Margin (41.7%) and Net Margin (15.0%). The stock shows characteristics typically associated with outperformers.
Our AI analyzes Thermo Fisher Scientific Inc.'s financial statements to generate buy/sell signals based on quantitative metrics, not market sentiment or news headlines. Here's what drives the 72% score:
Generate the full PDF report for complete category-by-category scoring and AI-powered investment recommendations.
Technical traders can view real-time demand and supply zones for TMO on our Demand Zones page. These zones identify key price levels where institutional buying or selling has historically occurred.
With TMO currently trading at $513.68, our system monitors proximity to these critical levels and can alert you when the stock approaches support or resistance zones.
Subscribe to demand zone alerts to receive real-time notifications when TMO reaches key technical levels.
Thermo Fisher Scientific Inc. operates in the Healthcare sector, specifically in Diagnostics & Research. Understanding earnings trends is crucial for forecasting TMO's trajectory.
Current revenue growth of 7.2% exceeds the average company.
Visit our Earnings Calendar to track upcoming TMO earnings dates and historical beat/miss patterns. Sign up for earnings alerts to get notified before announcements.
Our AI projects TMO's trajectory based on current fundamentals and historical patterns. With a 72% Strong Buy Score, here's what the data suggests:
Bullish Outlook: Thermo Fisher Scientific Inc. shows strong fundamental momentum. Net margins of 15.0% indicate pricing power and operational efficiency. Stocks with similar profiles have historically outperformed over 12-month periods.
For a complete 12-month price forecast with specific bull/bear scenarios, generate the full PDF report.
Understanding valuation is critical for determining if TMO is fairly priced. Here's the current snapshot:
Our AI weighs these metrics against growth rates and margin quality to determine if TMO offers compelling risk-adjusted returns at current prices.
Here's why investors are bullish on Thermo Fisher Scientific Inc.:
With a 72% Strong Buy Score, the bull case is well-supported by current fundamentals. The stock exhibits characteristics of quality compounders that tend to outperform long-term.
Every investment carries risk. Here are potential concerns for TMO investors:
The full PDF report includes a detailed bear case analysis with specific risk ratings for each category.
TMO Summary: Thermo Fisher Scientific Inc. earns a 72% Buy Score based on AI analysis of fundamental data. Trading at $513.68 with a $192.99B market cap, the stock shows strong fundamentals supporting a bullish 12-month outlook.
Bull Case: Gross Margin (41.7%), Net Margin (15.0%)
For the complete analysis with specific price considerations, growth projections, and AI-powered buy/hold/sell recommendations, generate your free TMO PDF report.